Maddalena Guandalini

8PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 01, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.

Damiano Marastoni, Elisa Colato, Matteo Foschi

|Jan 30, 2024
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis.

Albulena Bajrami, Agnese Tamanti, Angela Peloso

|Jan 24, 2023
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study.

Stefano Ziccardi, Anna Isabella Pisani, Gian Marco Schiavi

|Jan 21, 2023
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis.

Stefano Ziccardi, Francesca Benedetta Pizzini, Maddalena Guandalini

|Dec 23, 2022
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.

Valentina Mazziotti, Francesco Crescenzo, Agnese Tamanti

|Dec 10, 2021
Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis.

Silvia Cerea, Marta Ghisi, Marco Pitteri

Pageof 2

Frequent Collaborators

7 joint publications

Stefano Ziccardi

7 joint publications

Massimiliano Calabrese

4 joint publications

Francesco Crescenzo

3 joint publications

Marco Pitteri